Viridian Therapeutics to Webcast Veligrotug Part 3 THRIVE-2 Topline Outcomes on December 16, 2024 By Investing.com
- THRIVE-2 world section 3 medical trial evaluated efficacy and security of…
Beam Therapeutics Pronounces New Knowledge from BEACON Section 1/2 Medical Trial of BEAM-101 in Sickle Cell Illness at American Society of Hematology (ASH) Annual Assembly By Investing.com
All Seven Sufferers Handled with BEAM-101 Achieved Hemoglobin F (HbF) Induction of…
Janux Therapeutics CEO sells $1 million in inventory By Investing.com
David Alan Campbell, President and CEO of Janux Therapeutics, Inc. (NASDAQ:JANX), lately…
Rakovina Therapeutics Proclaims Personal Placement Providing By Investing.com
VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc.…
Roche to amass US agency Poseida Therapeutics in $1.5 billion deal By Reuters
ZURICH (Reuters) -Switzerland's Roche will purchase U.S. biopharma agency Poseida Therapeutics in…
Carisma Therapeutics Presents Promising New Preclinical Knowledge on Engineered Macrophages for the Remedy of Liver Fibrosis at AASLD The Liver Assembly ® 2024 By Investing.com
New preclinical outcomes help the anti-fibrotic potential of engineered macrophages in a…
Omega Therapeutics inventory hits 52-week low at $0.89 By Investing.com
In a difficult yr for Omega Therapeutics, the biotechnology agency's inventory has…
EcoR1 Capital sells $8.4 million in Tango Therapeutics inventory By Investing.com
SAN FRANCISCO—EcoR1 Capital, LLC, a big shareholder in Tango Therapeutics, Inc. (NASDAQ:TNGX),…
United Therapeutics shares rated Impartial by Ladenburg, goal lifted on Tyvaso gross sales energy By Investing.com
On Thursday, Ladenburg Thalmann up to date its monetary outlook on United…
Travere Therapeutics Presents Knowledge Reinforcing Scientific Advantage of FILSPARI ® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024 By Investing.com
Practically 60% of sufferers with IgAN within the SPARTAN Research achieved full…